PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

metoprolol Side Effects

The reactions most often reported to the FDA for metoprolol (also sold as Lopressor, Toprol-XL), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

246,252
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2001 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of metoprolol come from 246,252 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 246,252 reports to the FDA Adverse Event Reporting System (FAERS) for metoprolol (Lopressor): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

246,252

Reports Mentioning Death

27,931

11.3% of reports — not proof the medicine caused the death

Hospitalizations

96,962

39.4% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

FATIGUE
15,966
DYSPNOEA
14,128
DIARRHOEA
13,635
NAUSEA
13,398
DIZZINESS
11,699
DEATH
9,738
ASTHENIA
9,410
PAIN
9,111
FALL
9,084
HEADACHE
8,835
HYPOTENSION
7,535
VOMITING
7,128
PNEUMONIA
7,103
ARTHRALGIA
6,782
ATRIAL FIBRILLATION
6,687
WEIGHT DECREASED
6,449
ACUTE KIDNEY INJURY
6,382
MALAISE
6,379

Who Reports Side Effects

Gender Distribution

Female 122,554 (53%)
Male 107,692 (47%)
Unknown 297

Age Distribution

0-17 1,513 (1%)
18-44 11,591 (7%)
45-64 53,151 (31%)
65-74 49,186 (29%)
75+ 54,710 (32%)

Reporting Trend by Year

2001 2025

Reactions in Death Reports

Top reactions reported in 27,931 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 9,701
COMPLETED SUICIDE 3,471
TOXICITY TO VARIOUS AGENTS 1,693
CARDIAC ARREST 1,363
PNEUMONIA 1,354
RENAL FAILURE 1,289
DYSPNOEA 1,191
ACUTE KIDNEY INJURY 1,081
HYPOTENSION 1,043
SEPSIS 947
RESPIRATORY FAILURE 908
FALL 881
MYOCARDIAL INFARCTION 853
ASTHENIA 839
FATIGUE 810
NAUSEA 781
CARDIAC FAILURE CONGESTIVE 760
DIARRHOEA 754
CARDIO-RESPIRATORY ARREST 744

Reactions in Hospitalization Reports

Top reactions in 96,962 reports where hospitalization was an outcome.

Reaction Reports
DYSPNOEA 8,069
FALL 6,075
PNEUMONIA 5,839
FATIGUE 5,639
NAUSEA 5,487
DIARRHOEA 5,371
DIZZINESS 5,052
ASTHENIA 4,979
HYPOTENSION 4,867
ATRIAL FIBRILLATION 4,660
MYOCARDIAL INFARCTION 4,363
VOMITING 3,993
ACUTE KIDNEY INJURY 3,786
PAIN 3,746
ANAEMIA 3,740
HYPERTENSION 3,257
DEHYDRATION 3,224
CHEST PAIN 3,191
PYREXIA 3,136

Compare metoprolol vs acebutolol →

What the FAERS Data Reveals About metoprolol Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 246,252 voluntary reports linked to metoprolol and its brand equivalents (Lopressor, Toprol-XL), spanning 2001 through 2025. Of those, 27,931 (11.3%) listed death as an outcome and 96,962 (39.4%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 53% were female and 47% male; age distribution skews toward 75+, with 54,710 reports in that bracket. The single most reported reaction is fatigue with 15,966 submissions, followed by dyspnoea and diarrhoea.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.